tiprankstipranks
Abbott Labs (GB:0Q15)
LSE:0Q15

Abbott Labs (0Q15) Financial Statements

0 Followers

Abbott Labs Financial Overview

Abbott Labs's market cap is currently ―. The company's EPS TTM is $3.265; its P/E ratio is 34.22; and it has a dividend yield of 1.86%. Abbott Labs is scheduled to report earnings on April 17, 2024, and the estimated EPS forecast is $0.96. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 10.24B$ 10.14B$ 9.98B$ 9.75B$ 10.09B
Gross Profit$ 5.68B$ 5.54B$ 5.50B$ 5.42B$ 5.50B
EBIT$ 1.95B$ 1.84B$ 1.79B$ 1.72B$ 1.47B
EBITDA$ 2.77B$ 2.66B$ 2.60B$ 2.52B$ 2.28B
Net Income Common Stockholders$ 1.59B$ 1.44B$ 1.38B$ 1.32B$ 1.03B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.28B$ 7.05B$ 8.15B$ 9.53B$ 10.17B
Total Assets$ 73.21B$ 72.09B$ 73.40B$ 73.77B$ 74.44B
Total Debt$ 14.68B$ 15.53B$ 16.85B$ 16.90B$ 17.72B
Net Debt$ 7.40B$ 8.48B$ 8.69B$ 7.37B$ 7.55B
Total Liabilities$ 34.39B$ 34.40B$ 35.95B$ 36.56B$ 37.53B
Stockholders Equity$ 38.60B$ 37.48B$ 37.17B$ 37.01B$ 36.69B
Cash Flow-
Free Cash Flow$ 2.28B$ 1.32B$ 696.00M$ 763.00M$ 1.72B
Operating Cash Flow$ 3.04B$ 1.88B$ 1.20B$ 1.14B$ 2.33B
Investing Cash Flow$ -824.00M$ -634.00M$ -1.21B$ -462.00M$ -632.00M
Financing Cash Flow$ -2.05B$ -2.34B$ -1.29B$ -1.41B$ -1.46B
Currency in USD

Abbott Labs Earnings and Revenue History

Abbott Labs Debt to Assets

Abbott Labs Cash Flow

Abbott Labs Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis